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DEALING WITH COMPETING CAUSES OF DEATH, ILLNESS
AND COSTS:THE DISEASE ELIMINATION LIFETABLE
ANALYSIS (DELTA) MODEL
Van der Steen A,Verheggen BG, Heeg BMS,Van Hout BA
Pharmerit Europe, Rotterdam,The Netherlands
OBJECTIVES: The Disease Elimination Life Table Analysis
(DELTA) approach allows deterministic modelling of interven-
tions which affect the incidence of several diseases, such as
smoking cessation, hormone therapy and diabetes prevention,
without causing the number of health states to explode. To
analyse the differences of applying the DELTA approach to an
individual patient simulation model for modelling diabetes.
METHODS: Five diseases are modelled; macrovascular disease
(including MI’s and strokes), heart failure, retinopathy, renal
disease and peripheral vascular disease. The price for modelling
these diseases deterministically is three assumptions concerning
independence: the probability to get a disease (to die) in sub-
model A is independent of the probability to get a disease (to die)
in sub-model B. The same UK Prospective Diabetes Study
(UKPDS) risk equations are used in the patient simulation model
as in the DELTA model. Using both models estimates are
obtained and compared concerning life expectancies and the time
in different diseases. Probabilistic sensitivity analyses are carried
out to obtain conﬁdence intervals surrounding the estimates.
RESULTS: The expected life time QALY’s for females of ages 47,
52, 57, and 62 in the UKPDS and DELTA models are 20.2, 17.9,
15.7 and 13.5, and 20.1, 17.6, 15.1, and 13.2 respectively. Simi-
larly for males the expected life time QALY’s in both models are
19.0, 16.2, 13.6, and 11.1 and 18.9, 16.0, 13.3, and 10.34
respectively. The time needed for a probabilistic sensitivity analy-
sis with 100 draws from the uncertainty distribution is approxi-
mately 10 seconds. CONCLUSION: The DELTA approach offers
a ﬂexible way to model multiple diseases at the same time. The
underlying independency assumptions—which may restrict its
need—do not seem to affect the outcomes in the case of model-
ling diabetes. The loss in terms of subtlety seem to be outweighed
by the gains in clarity and computational speed.
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DRUG ADMINISTRATION SERVICES:AN INFUSION STAGE
MODEL IN A MULTI-SITE STUDY OF U.S. PHYSICIAN OFFICES
Baker JJ1, Pierce CA2
1The Resource Group, Pickton,TX, USA, 2The Resource Group,
Richﬁeld, OH, USA
OBJECTIVES: Drug administration via intravenous infusion is
an important incident-to service for numerous U.S. physician
practices. Effective stafﬁng and patient scheduling can be better
achieved by recognizing the individual components of the infu-
sion activity. This project built a detailed infusion model and
applied it to multi-site infusion observations. METHODS: A
model of drug administration activity via intravenous infusion as
performed in the physician’s ofﬁce was created that deﬁned a
series of individual tasks divided into sequential stages. The
model was then applied to observations of infusions in 75 phy-
sician ofﬁces located in 26 states. Observation instruments were
pretested. The sampling frame was a broad-based convenience
sample. Measures were taken to ensure a representative sample
as to practice type and size. Observation data were recorded in a
database. Unit of analysis was the individual physician ofﬁce.
Statistical analysis yielded descriptive statistics. RESULTS: The
activity analysis model consisted of sequential service types (pre-;
intra-; and post-service) comprised of 48 tasks. Intraservice tasks,
representing the overall infusion activity, were divided into four
stages. On-site observers applied the model in time-and-motion
observations. Mean direct labor time totaled 129.7 minutes, of
which 111.9 minutes per patient (86%) was intraservice.
Intraservice therapy administration was divided into two sub-
stages. Sub-stage 1 consisted of tasks to commence the infusion,
while sub-stage 2 consisted of patient monitoring after the drug
began to ﬂow. The mean direct labor time for infusion sub-stage
1 totaled 20.5 minutes (16%), while infusion sub-stage 2 totaled
79.9 minutes (62%). Only minor variations in infusion protocol
were observed. CONCLUSION: Physician ofﬁce decision-
makers need actionable methods in order to better manage drug
administration services and to increase patient satisfaction. This
study provides important detailed activity analysis information
and process mapping that can be readily applied to practice-
speciﬁc relevant scheduling, stafﬁng and management decisions.
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NONLINEAR SMOOTHINGTO ASSESS PROBABILITIES OF
ANTIBIOTIC-RESISTANT INFECTIONS INTHE COMUNITAT
VALENCIANA (SPAIN)
Armero C1,Albert R1, López-Quílez A1, Muñoz I2,Vanaclocha H2
1Universitat de València,València, Spain, 2Generalitat Valenciana,
València, Spain
OBJECTIVES: Resistance to antibiotics is a serious public health
problem with an increasing economical impact. A wide knowl-
edge of the evolution and characteristics of these bacterial is thus
critical to manage and develop treatment and prevention strate-
gies. The main goal of this study is assessing probabilities of
MRSA infection in the Comunitat Valenciana according to
hospital and nonhospital setting, gender, age and specimen.
METHODS: Data are supplied by RedMIVA, the microbiologi-
cal surveillance network that collects information from the
public microbiology laboratories. A total of 2034 determinations
are recorded from January to June 2006. The statistical model is
a Generalised Additive Model with gender, hospital and nonhos-
pital setting and specimen as factors, and the age as a covariate
included in the model as a nonlinear term with splines RESULTS:
The expected estimated probability of MRSA is less in women
than in men in all the ages. The exception occurs in hospitalised
women aged 20 to 40 which exhibit signiﬁcant ﬂuctuations.
Urine and oftalmological specimen produce always the largest
and smallest probabilities. The ﬁtted model allows the estimation
of probabilities of MRSA for any combination of the factor levels
and age. For example, in the case of urine specimen, the posterior
expected probability in hospitalised (nonhospitalised) men with
ages 20, 40, 60 and 80 is 0.3974 (0.2236), 0.5127 (0.2608),
0.6753 (0.5062) and 0.8094 (0.73332), respectively. In the group
of urine specimen supplied by hospitalised (nonhospitalised)
women the results are 0.3354 (0.4720), 0.5400 (0.009), 0.6716
(0.4473) and 0.6463 (0.5458) for ages 20, 40, 60 and 80, respec-
tively. CONCLUSION: We have ﬁtted an stochastic model for
learning about MRSA that essentially captures its behaviour in
the population. The probabilities of MRSA are, in general, higher
for men than women. They increase as people get old but its
difference decreases with age.
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ORDINAL OR CARDINAL?THEVAS STRIKES BACK
Chuang LH, Kind P
University of York,York, UK
OBJECTIVES: Visual analogue scales (VAS) are widely used to
value health. The relative merits of VAS include minimal cogni-
tive burden, ease of administration and low cost. Additionally,
psychometric performance can be quite robust. However, the
legitimacy of VAS-generated values in economic evaluation is
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often challenged despite recent literature that advocates a more
sympathetic assessment. Integral to this debate is the question of
whether VAS-based methods generate cardinal scales necessary
for economic evaluation. This study reports on that issue.
METHODS: A UK postal survey was used to elicit values for all
243 health states deﬁned by EQ-5D. A factorial block design was
used to construct 21 questionnaire versions in which a sample of
14 EQ-5D health states were valued by each respondent. Data
were obtained from 825 participants. Health states were ranked
in terms of their VAS scores on a within-respondent basis and
analysed using a conditional logit model to obtain estimated
values on an interval scale. The estimated values were compared
with directly observed VAS values rescaled so that the best state
(11111) was 100 and the worst state (33333) was 0. RESULTS:
The estimated values derived from this analysis were as much as
10 points higher than the rescaled, directly observed VAS scores.
Some differences in the rank order of health states were seen in
the two sets of values. However, a generally linear pattern was
seen between the computed and observed VAS values with a
Pearson correlation coefﬁcient as 0.969. OLS regression con-
ﬁrmed this relationship between estimated and observed VAS
values with the estimated value = VAS value*1.079 + 5.527.
CONCLUSION: Convergence between the two sets of values
conﬁrms the interval scale properties of the VAS value set, con-
ﬁrming the necessary cardinal measurement property to be legiti-
mately used in economic evaluation.
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OBJECTIVES: Generic Quality-of-life (QoL) instruments allow
to compare QoL in populations different for culture, languages,
health. If utilities are derivable, QoL data can be used in eco-
nomic research. Unfortunately children often remain excluded
from being part of these populations, hence information for
optimal decision-making in pediatric context can be limited. The
Child-Task-Force operating within the EuroQoL group is trans-
lating and validating a EQ-5D child version. Within the Child-
Task-Force, the Italian team conducted a validation study
involving 8–15 years old children in Italy. METHODS: Children
from general population were enrolled at schools, those with
chronic diseases enrolled at hospitals. Participants self-completed
a core-set containing: EQ-5D(child), open-questions on reasons
why they reported “no”, “some”, “a lot of” problems with each
EQ-5D-domain, standard measures for comparisons like
PEDsQL, a scale to self-rate global health, the World-Health-
Organization health scale, questions on demographic, socio-
economic, health status. After 10 days some kids underwent to a
re-test interview. Convergent and Discriminant validities were
tested by computing correlation coefﬁcients between every
couple of items/scores, as appropriate; concurrent validity was
tested by comparing the EQ-5D(child) responses of chronically
sick versus general population children; reliability was tested by
calculating agreement levels of test with re-test responses.
RESULTS: In total, 415 valid children from schools (31.1% were
re-tested), 11 Acute Linfoblastic Leukaemia patients form hospi-
tals were enrolled. Relevant Spearman’s correlation coefﬁcients
(>0.2, p < 0.0001) were found between every conceptually
similar items/scores; not signiﬁcant coefﬁcients were found
between most of not conceptually similar items. Weighted
Cohen’s Kappa were 0.2–0.5 in the proﬁle items. Intraclass-
Correlation-Coefﬁcient for VAS = 0.715. Leukaemia patients
more frequently reported problems/trouble in every EQ-5D item,
lower median (92.5 vs 98.0) and mean (83.0 vs 93.9) VAS.
CONCLUSION: EQ-5D(child) shows acceptable levels of valid-
ity and reliability. Further research will be conducted to improve
its properties and allow appropriate use in both research and
clinical practice.
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SF-6D REFERENCEVALUES FOR SPANISH
GENERAL POPULATION
Morís J1, Rebollo P2,Alonso J3, Cuervo J2, Zardain PC2, Ferrer M3,
Vilagut G3
1Malaga University and BAP Health Outcomes, Málaga, Spain,
2BAP Health Outcomes Research, Oviedo, Asturias, Spain,
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OBJECTIVES: SF-6D is an utility index, recently developed and
which has been validated for its use in Spanish population. It was
derived from SF-36 Health Survey, the most frequently used
generic HRQoL assessment instrument. Spanish general popula-
tion values for the SF-6D are presented here, along with some of
its characteristics and the comparison of two ways of using those
values. METHODS: The original database used to obtain the
General Population norms of the SF-36 in our country was used
in present analysis. This database includes the SF-36 data of
9151 non institutionalized subjects aged over 18, obtained in a
cross-sectional study of a random selected sample from GP.
SF-6D was calculated with and without the weights which rep-
resent the preferences of population about different health status.
The formula and the weights used were those used in the original
SF-6D version (Brazier et al). RESULTS: SF-6D score was higher
in males tan in females (F1.8975 = 177.467; p < 0.01). Statistically
signiﬁcant differences were observed in the SF-6D score among
different age groups (F6.8975 = 188.262; p < 0.01), lower scores
corresponding to elder age groups. There was a signiﬁcant inter-
action between both factors (F6.8975 = 5.456; p < 0.01). Variance
of SF-6D scores increases with the age. Direct SF-6D score
(without weights) and that obtained with weights of previous
preferences studies showed a high correlation (þ = 0.953;
p < 0.01; R2 = 0.91) CONCLUSION: Values calculated in
present analysis may be used as a reference for the SF-6D in
Spanish GP. They will allow a better interpretation of scores in
concrete groups of patients and in the individual patient (with
respect to age and gender). Results show that the use of weights
obtained in preference studies may not have the expected
relevance.
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ACCOUNTING FOR INITIAL HEALTH STATUS IN MEASURING
THE BENEFITS OF HEALTH CARETECHNOLOGIES
Taylor MJ
University of York,York, UK
OBJECTIVES: In current economic evaluation methods, ‘QALYs
gained’ is used as a summary outcome. The value of a patient
moving from a health state with utility 0.8 to full health (i.e. 1.0)
is considered equivalent to a change from 0.3 to 0.5, since both
show ‘improvements’ of 0.2. However, there is evidence to
suggest that the initial state may play an important role in the
patient’s own valuation of the health change. That is, the more
severe the initial state, the more a patient will value an ‘equal’
health gain. METHODS: Two experiments were developed,
using the visual analogue scale (VAS) and health utilities index
3 (HUI:3) methods of presenting health states. Participants
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